2022
Molecular Imaging in Acute Aortic Syndrome Lighting a Path to Better Risk Assessment ∗
Tawakol A, Mezue K. Molecular Imaging in Acute Aortic Syndrome Lighting a Path to Better Risk Assessment ∗. JACC Cardiovascular Imaging 2022, 15: 1305-1307. PMID: 35798406, DOI: 10.1016/j.jcmg.2022.04.022.Peer-Reviewed Original Research
2017
Visit‐to‐visit systolic blood pressure variability predicts treatment‐related adverse event of hyponatremia in SPRINT
Goyal A, Mezue K, Rangaswami J. Visit‐to‐visit systolic blood pressure variability predicts treatment‐related adverse event of hyponatremia in SPRINT. Cardiovascular Therapeutics 2017, 35 PMID: 28544636, DOI: 10.1111/1755-5922.12274.Peer-Reviewed Original ResearchConceptsVisit-to-visit systolic blood pressure variabilitySystolic blood pressureSystolic blood pressure variabilityTarget blood pressureBlood pressureBlood pressure variabilitySPRINT trialAdverse eventsSystolic blood pressure <Occurrence of hyponatremiaCox proportional hazards regressionRisk of hyponatremiaBlood pressure <Coefficient of variation of systolic blood pressureProportional hazards regressionStandard treatment groupCardiovascular risk factorsPressure variabilityOverall cohortTreatment armsTreatment subgroupsHazards regressionInclusion criteriaCoefficient of variationHyponatremia
2016
QRS duration predicts left ventricular systolic function following ST elevation myocardial infarction
Maludum O, Nwakile C, Mezue K, Shah M, Purushottam B, Morris D, Figueredo V. QRS duration predicts left ventricular systolic function following ST elevation myocardial infarction. International Journal Of Cardiology 2016, 207: 300-302. PMID: 26814632, DOI: 10.1016/j.ijcard.2016.01.182.Peer-Reviewed Original Research